Send the following on WhatsApp
Continue to Chathttps://www.bfmtv.com/economie/patrimoine/placements-epargne/les-capsules-xtandi-enzalutamide-recoivent-l-avis-favorable-du-chmp-pour-le-traitement-des-hommes-atteints-d-un-cancer-de-la-prostate-metastatique-resistant-a-la-castration-qui-n-ont-encore-jamais-recu-de-chimiotherapie_AN-201410250029.html